During the past decade, Cardiovascular Innovation and Research Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiovascular Innovation and Research Center" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Cardiovascular Innovation and Research Center" are "Cardiac Arrhythmia" (1 trials), "Myocardial Infarction" (1 trials) and "Venous Thromboembolism" (1 trials). Many other conditions were trialed in "Cardiovascular Innovation and Research Center" in a lesser frequency.

Most popular intervention types in "Cardiovascular Innovation and Research Center" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Arrhythmia Management System (AMS)" (1 trials), "Empagliflozin" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular Innovation and Research Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Cardiovascular Innovation and Research Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Cardiovascular Innovation and Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular Innovation and Research Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".